Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$259.69+3.34 (+1.30%)
Close on Nov 18, 2026Market cap $28.57BP/E 25.9Yield –
Quest Diagnostics r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Quest Diagnostics
Quest Diagnostics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?